A Randomized, Open-label, Parallel-group, Multicenter Study to Determine the Efficacy and Long-term Safety of Albiglutide Compared With Insulin in Subjects With Type 2 Diabetes Mellitus.
A Randomized, Open-label, Parallel-group, Multicenter Study to Determine the Efficacy and Long-term Safety of Albiglutide Compared With Insulin in Subjects With Type 2 Diabetes Mellitus.
A study to determine the safety and efficacy of albiglutide in subjects with type 2 diabetes.
Inclusion Criteria:
Exclusion Criteria:
Satna Monica, California 90404, United States
Ponte Verda, Florida 32081, United States
Downington, Pennsylvania 19335, United States
Landsdale, Pennsylvania 19446, United States
Sugarland, Texas 77479, United States